Fifth Lane Capital »

Nektar Therapeutics shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $256k 4.5k 56.90

More positions owned by Fifth Lane Capital

Ishares Tr Core S&p500 Etf (IVV)
Renatus Tactical Acquis Shs Cl A (RTAC)
C1 Common Stock
Cantor Equity Partners Ii In Cl A Ord Shs (CEPT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Procap Acquisition Corp Shs Cl A
Cantor Equity Partners Iii I Shs Cl A (CAEP)
Futurecrest Acquisition Corp Unit 99/99/9999
M3brigade Acquisition V Corp Cl A (MBAV)
Wen Acquisition Corp Com Cl A
Columbus Circle Cap Corp. I Shs Cl A (BRR)
Btc Dev Corp Unit 09/11/2030
UnitedHealth (UNH)
Republic Digital Acquisition Usd Cl A Ord Shs (RDAG)
Live Oak Acquisition Corp V Cl A Shs (LOKV)

View all positions for Fifth Lane Capital

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics